Bispecific antibodies

The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed more than 25 years ago. However, initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. A...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Springer ebooks.
مؤلف مشترك: SpringerLink (Online service)
مؤلفون آخرون: Kontermann, Roland 1961- (المحرر)
التنسيق: Electronic Resource
اللغة:English
منشور في: Berlin, Heidelberg Springer Berlin Heidelberg c2011
الموضوعات:
الوصول للمادة أونلاين:Available for University of the Philippines Diliman via SpringerLink. Click here to access